Fidia Advanced Biopolymers Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Abano Terme Italy (1992)
Status: Acquired by Anika Therapeutics, Inc. (2009)

Organization Overview

First Clinical Trial
2010
NCT04661826
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Fidia Farmaceutici s.p.a. | Fidia Pharma USA Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Back Pain (Phase 4)

Carcinoma, Papillary (Phase 2)

Low Back Pain (Phase 4)

Urinary Bladder Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 8